ERBB2 and breast cancer: A typical example is the subtype heterogeneity in breast cancer, in which the estrogen receptor (ER)-positive breast cancer subtype responds well to hormone therapy, while the human epidermal growth factor receptor 2 (HER2)-positive breast cancer subtype responds well to chemotherapy [6].